Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
IMMUNOBIOLOGY (2013)
期刊
IMMUNOBIOLOGY
卷 218, 期 11, 页码 1385-1391出版社
ELSEVIER GMBH
关键词
类别
作者
我是这篇论文的作者
推荐
Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection
Manuel Fresno, Nuria Girones
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Arginine Signaling and Cancer Metabolism
Chia-Lin Chen, Sheng-Chieh Hsu, David K. Ann, Yun Yen, Hsing-Jien Kung
CANCERS (2021)
Novel perspectives on redox signaling in red blood cells and platelets in cardiovascular disease
Ali Mahdi, Miriam M. Cortese-Krott, Malte Kelm, Nailin Li, John Pernow
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Myeloid-Derived Suppressor Cells (MDSCs) and the Immunoinflammatory Response to Injury (Mini Review)
Shannon R. Sayyadioskoie, Martin G. Schwacha
SHOCK (2021)
Arginine-dependent immune responses
Adria-Arnau Lindez, Walter Reith
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis
Mengfan Zhang, Zongmei Wu, Sandra Serna Salas, Magnolia Martinez Aguilar, Maria C. Trillos-Almanza, Manon Buist-Homan, Han Moshage
JOURNAL OF CELLULAR BIOCHEMISTRY (2023)
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Yuze Wu, Ming Yi, Mengke Niu, Qi Mei, Kongming Wu
MOLECULAR CANCER (2022)
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
Andreia Matos, Marcos Carvalho, Manuel Bicho, Ricardo Ribeiro
NUTRIENTS (2021)
L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction
Celine Erens, Jana Van Broeckhoven, Cindy Hoeks, Gernot Schabbauer, Paul N. Cheng, Li Chen, Niels Hellings, Bieke Broux, Stefanie Lemmens, Sven Hendrix
BIOMEDICINES (2022)
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
Paola Del Bianco, Laura Pinton, Sara Magri, Stefania Cane, Elena Masetto, Daniela Basso, Marta Padovan, Francesco Volpin, Domenico d'Avella, Giuseppe Lombardi, Vittorina Zagonel, Vincenzo Bronte, Alessandro Della Puppa, Susanna Mandruzzato
FRONTIERS IN IMMUNOLOGY (2022)
Arginine Dysregulation and Myocardial Dysfunction in a Mouse Model and Children with Chronic Kidney Disease
Loretta Z. Z. Reyes, Pamela D. D. Winterberg, Roshan Punnoose George, Michael Kelleman, Frank Harris, Hanjoong Jo, Lou Ann S. Brown, Claudia R. R. Morris
NUTRIENTS (2023)
Arginine metabolism and its functions in growth, nutrient utilization, and immunonutrition of fish
Qingchao Wang, Zhen Xu, Qinghui Ai
ANIMAL NUTRITION (2021)
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
Matthew J. Dean, Juan B. Ochoa, Maria Dulfary Sanchez-Pino, Jovanny Zabaleta, Jone Garai, Luis Del Valle, Dorota Wyczechowska, Lyndsey Buckner Baiamonte, Phaethon Philbrook, Rinku Majumder, Richard S. Vander Heide, Logan Dunkenberger, Ramesh Puttalingaiah Thylur, Bobby Nossaman, W. Mark Roberts, Andrew G. Chapple, Jiande Wu, Chindo Hicks, Jack Collins, Brian Luke, Randall Johnson, Hari K. Koul, Chris A. Rees, Claudia R. Morris, Julia Garcia-Diaz, Augusto C. Ochoa
FRONTIERS IN IMMUNOLOGY (2021)
Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression
Lijun Li, Wenjie You, Xuewen Wang, Yulian Zou, Hong Yao, Hailin Lan, Xinhua Lin, Qiuyu Zhang, Bing Chen
PHYTOMEDICINE (2023)
There is no direct competition between arginase and nitric oxide synthase for the common substrate L-arginine
Tony Y. Momma, Javier I. Ottaviani
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2022)
Imaging and therapeutic targeting of the tumor immune microenvironment with biologics
Sana Arnouk, Timo W. M. De Groof, Jo A. Van Ginderachter
ADVANCED DRUG DELIVERY REVIEWS (2022)
Single-cell RNA and protein profiling of immune cells from the mouse brain and its border tissues
Isabelle Scheyltjens, Hannah Van Hove, Karen De Vlaminck, Daliya Kancheva, Jonathan Bastos, Monica Vara-Perez, Ana Rita Pombo Antunes, Liesbet Martens, Charlotte L. Scott, Jo A. Van Ginderachter, Yvan Saeys, Martin Guilliams, Niels Vandamme, Kiavash Movahedi
NATURE PROTOCOLS (2022)
The Heat Is On: 20-HETE Instructs an Immunosuppressive Phenotype in Cancer-Associated Fibroblasts
Jo A. Van Ginderachter
CANCER RESEARCH (2022)
Differential plasticity and fate of brain-resident and recruited macrophages during the onset and resolution of neuroinflammation
Karen De Vlaminck, Hannah Van Hove, Daliya Kancheva, Isabelle Scheyltjens, Ana Rita Pombo Antunes, Jonathan Bastos, Monica Vara-Perez, Leen Ali, Myrthe Mampay, Lauren Deneyer, Juliana Fabiani Miranda, Ruiyao Cai, Luc Bouwens, Dimitri De Bundel, Guy Caljon, Benoit Stijlemans, Ann Massie, Jo A. Van Ginderachter, Roosmarijn E. Vandenbroucke, Kiavash Movahedi
IMMUNITY (2022)
Enteric glial cells favor accumulation of anti-inflammatory macrophages during the resolution of muscularis inflammation
Michelle Stakenborg, Saeed Abdurahiman, Veronica De Simone, Gera Goverse, Nathalie Stakenborg, Lies van Baarle, Qin Wu, Dimitri Pirottin, Jung-Seok Kim, Louise Chappell-Maor, Isabel Pintelon, Sofie Thys, Emilie Pollenus, Louis Boon, Philippe Van den Steen, Marlene Hao, Jo A. Van Ginderachter, Guy E. Boeckxstaens, Jean-Pierre Timmermans, Steffen Jung, Thomas Marichal, Sales Ibiza, Gianluca Matteoli
MUCOSAL IMMUNOLOGY (2022)
GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide
Sweta Parik, Juan Fernandez-Garcia, Francesca Lodi, Karen De Vlaminck, Marleen Derweduwe, Steven De Vleeschouwer, Raf Sciot, Wietse Geens, Linqian Weng, Francesca Maria Bosisio, Gabriele Bergers, Johnny Duerinck, Frederick De Smet, Diether Lambrechts, Jo A. Van Ginderachter, Sarah-Maria Fendt
FRONTIERS IN ONCOLOGY (2022)
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting
Marco Erreni, Francesca D'Autilia, Roberta Avigni, Evangelia Bolli, Sana M. Arnouk, Kiavash Movahedi, Pieterjan Debie, Achille Anselmo, Raffaella Parente, Cecile Vincke, Fijs W. B. van Leeuwen, Paola Allavena, Cecilia Garlanda, Alberto Mantovani, Andrea Doni, Sophie Hernot, Jo A. Van Ginderachter
THERANOSTICS (2023)
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment
Mate Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, Pauline M. R. Bardet, Sana M. Arnouk, Cleo Goyvaerts, Johan Swinnen, Frank Aboubakar Nana, Jo A. Van Ginderachter, Damya Laoui
FRONTIERS IN IMMUNOLOGY (2022)
Hallmarks of Cancer Affected by the MIF Cytokine Family
Romina Mora Barthelmess, Benoit Stijlemans, Jo A. Van Ginderachter
CANCERS (2023)
A few good reasons to use nanobodies for cancer treatment
Neema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, Geert Raes, Timo W. M. De Groof, Nick Devoogdt, Benoit Stijlemans, Cecile Vincke, Jo A. Van Ginderachter
EUROPEAN JOURNAL OF IMMUNOLOGY (2023)
Current status and future expectations of nanobodies in oncology trials
Tessa De Pauw, Lynn De Mey, Jens M. Debacker, Geert Raes, Jo A. Van Ginderachter, Timo W. M. De Groof, Nick Devoogdt
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2023)
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Karine Breckpot, Quentin Lecocq, Lore Decoster, Christel Fontaine, Denis Schallier, Sandrine Aspeslagh, Ilse Vaneycken, Geert Raes, Jo A. Van Ginderachter, Tony Lahoutte, Vicky Caveliers, Marleen Keyaerts
JOURNAL OF NUCLEAR MEDICINE (2023)
Flt3L therapy increases the abundance of Treg-promoting CCR7(+) cDCs in preclinical cancer models
Emile J. Clappaert, Daliya Kancheva, Jan Brughmans, Ayla Debraekeleer, Pauline M. R. Bardet, Yvon Elkrim, Dagmar Lacroix, Maida Zivalj, Ahmed E. I. Hamouda, Jo A. Van Ginderachter, Sofie Deschoemaeker, Damya Laoui
FRONTIERS IN IMMUNOLOGY (2023)
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Maida Zivalj, Jo A. Van Ginderachter, Benoit Stijlemans
CANCERS (2023)
Self-Immolative Nanobody-Cysteine Residue Modification for Controlled Immunodrug Delivery
Maximilian Scherger, Yannick A. A. Pilger, Judith Stickdorn, Patric Komforth, Sascha Schmitt, Sana M. M. Arnouk, Els Lebegge, Kaloian Koynov, Hans-Joachim Rader, Jo A. A. Van Ginderachter, Lutz Nuhn
ADVANCED THERAPEUTICS (2023)